Empresas CMPC (CMPC) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
24 Nov, 2025Executive summary
Third quarter 2025 sales were $1,865 million, down 2% quarter-over-quarter and 6% year-over-year, with EBITDA at $260 million (13.9–14.0% margin) and net income at $34 million, reflecting declines due to lower pulp prices and the absence of non-core asset sales.
EBITDA declined 22% QoQ and 40% YoY, and net income dropped 58% QoQ and 77% YoY, mainly due to lower pulp prices and negative FX effects.
Financial highlights
Pulp EBITDA was $162 million (22.5% margin), Softys $95 million (10.9–11% margin), and BioPackaging $18 million (6.8% margin).
Pulp sales were $721 million, Softys $873 million, and BioPackaging $266 million.
Operating costs increased 1–1.5% QoQ and 3% YoY.
CapEx for the quarter was $67–176 million, down from the previous quarter.
Free cash flow was -$18 million in 3Q25.
Outlook and guidance
Management expects deleveraging as pulp prices recover, with further liquidity possible from monetizing non-core assets.
Pulp price increases have been implemented in China and are expected to continue globally, though long fiber remains weak.
Softys is targeting a 15% margin by late 2026 or early 2027, focusing on brand and cost optimization amid high competition and currency headwinds.
Forward-looking statements highlight risks and uncertainties, including those in financial disclosures.
Latest events from Empresas CMPC
- EBITDA margin rose to 20% as pulp outperformed, despite lower sales and net income.CMPC
Q2 20242 Feb 2026 - Q4 2025 sales hit $1.9B, EBITDA $262M, net income $37M, with pulp leading growth.CMPC
Q4 20252 Feb 2026 - $4.5B Natureza project, cost cuts, and Softys growth drive sustainability and innovation.CMPC
Investor Day 202419 Jan 2026 - 3Q24 EBITDA and net income surged, driven by Pulp, with Softys lagging.CMPC
Q3 202415 Jan 2026 - Q4 2024: sales and net income declined, but EBITDA and leverage improved.CMPC
Q4 20249 Jan 2026 - Q2 2025 saw $1.9B sales, EBITDA growth, asset sales, and major restructuring.CMPC
Q2 202523 Nov 2025 - Q1 2025: $1.813B sales, $278M EBITDA, $50M net income; Pulp strong, Softys and biopackaging pressured.CMPC
Q1 202519 Nov 2025 - CMPC seeks to modernize bond covenants while maintaining robust financial health and growth plans.CMPC
Corporate Presentation13 Jun 2025 - CMPC leads in pulp, tissue, and biopackaging with top sustainability and growth initiatives.CMPC
Corporate Presentation13 Jun 2025